EGFR and adenoma: Tjalma and co-workers initially analyzed the specific binding of anti-vascular endothelial growth factor (VEGF) and anti-epidermal growth factor receptor (EGFR) antibodies to hyperplastic (benign) polyps, various types of adenomas and colorectal cancer samples (34).